Development of an Adaptive Treatment for Weight Loss in People with Prediabetes
- Conditions
- PreDiabetesObesity
- Interventions
- Behavioral: Reduced Carbohydrate DietBehavioral: High Carbohydrate Diet
- Registration Number
- NCT04745572
- Lead Sponsor
- University of Alabama at Birmingham
- Brief Summary
This 16-week study will use an experimental approach called the Sequential Multiple Assignment Randomized Trial to help determine which combination and sequence of weight loss program features are most effective in people who are at risk for type 2 diabetes. Participants in the study will be initially randomized to consume either a high or reduced carbohydrate diet. After 4 weeks, participants will be identified as Responders (greater than or equal to 2.5% weight loss) or Non-Responders (less than 2.5% weight loss). Responders will continue with their initial randomized group for the remainder of the trial. Non-responders will be re-randomized to 2nd stage interventions of either including additional exercise counseling and training or beginning a time restricted eating protocol for the remainder of the trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
- 18-75 years of age
- BMI of 27 kg/m2 or greater
- at risk for developing type 2 diabetes (prediabetes)
- Pregnant, planning to become pregnant, or breastfeeding
- uncontrolled hypo or hyperthyroidism
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description Reduced Carbohydrate Diet Reduced Carbohydrate Diet Enrollment in a group-based behavioral weight loss intervention based on the Diabetes Prevention Program curriculum with reduced carbohydrate diet plan. High Carbohydrate Diet High Carbohydrate Diet Enrollment in a group-based behavioral weight loss intervention based on the Diabetes Prevention Program curriculum with high carbohydrate diet plan.
- Primary Outcome Measures
Name Time Method Change in insulin week 16 visit Serum insulin will be measured in a fasted state.
Changes in body weight week 16 visit Measured on digital scale at final visit.
Change in glucose week 16 visit Serum glucose will be measured in a fasted state.
Changes in lipids week 16 visit Fasting serum concentrations of total cholesterol, HDL cholesterol, triglycerides, and LDL cholesterol
Changes in fat mass week 16 visit As measured by bioelectrical impedance analysis (BIA) on the InBody S10 body composition analyzer.
Changes in QUICKI index week 16 visit Predictor of insulin resistance that will be calculated from glucose and insulin measures
- Secondary Outcome Measures
Name Time Method Changes in overall strength week 16 visit As measured by hand grip dynamometry
Changes in aerobic fitness week 16 visit As measured by the 3-minute step test.
Diet Intake and Physical Activity Monitoring week 16 visit 7-day food logs and weekly physical activity logs
Trial Locations
- Locations (1)
UAB Highlands Family and Community Medicine Clinic
🇺🇸Birmingham, Alabama, United States